Retinoic Acid Modulates Retinaldehyde Dehydrogenase 1 Gene Expression Through the Induction of GADD153-C/EBPbeta Interaction

Overview

Journal Biochem Pharmacol

Specialties Biochemistry
Pharmacology

Date 2008 Nov 11

PMID 18992716

Citations 21

Authors

Guillermo Elizondo

Irma M Medina-Diaz

Raymundo Cruz

Frank J Gonzalez

Libia Vega

Affiliations

Soon will be listed here.

Abstract

Mammalian class I aldehyde dehydrogenase (ALDH) plays an important role in the biosynthesis of the hormone retinoic acid (RA), which modulates gene expression and cell differentiation. RA has been shown to mediate control of human ALDH1 gene expression through modulation of the retinoic acid receptor alpha (RARalpha) and the CCAAT/enhancer binding protein beta (C/EBPbeta). The positive activation of these transcription factors on the ALDH1 promoter is inhibited by RA through a decrease of C/EBPbeta binding to the ALDH1 CCAAT box response element. However, the mechanism of this effect remains unknown. Here we report that the RARalpha/retinoid X receptor beta (RXRbeta) complex binds to the mouse retinaldehyde dehydrogenase 1 (Raldh1) promoter at a non-consensus RA response element (RARE) with similar affinity to that of the consensus RARE. We found that C/EBPbeta binds to a Raldh1 CCAAT box located at -82/-58bp, adjacent to the RARE. Treatment with RA increases GADD153 and GADD153-C/EBPbeta interaction resulting in a decreased cellular availability of C/EBPbeta for binding to the Raldh1 CCAAT box. These data support a model in which high RA levels inhibit Raldh1 gene expression by sequestering C/EBPbeta through its interaction to GADD153.

Citing Articles

Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers.

Lavudi K, Nuguri S, Olverson Z, Dhanabalan A, Patnaik S, Kokkanti R Front Cell Dev Biol. 2023; 11:1254612.

PMID: 37645246 PMC: 10461636. DOI: 10.3389/fcell.2023.1254612.

Retinoid metabolism: new insights.

Gudas L J Mol Endocrinol. 2022; 69(4):T37-T49.

PMID: 35900851 PMC: 9561048. DOI: 10.1530/JME-22-0082.

Mechanisms of Feedback Regulation of Vitamin A Metabolism.

OConnor C, Varshosaz P, Moise A Nutrients. 2022; 14(6).

PMID: 35334970 PMC: 8950952. DOI: 10.3390/nu14061312.

All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells.

Yao W, Wang L, Huang H, Li X, Wang P, Mi K BMC Cancer. 2020; 20(1):315.

PMID: 32293355 PMC: 7161137. DOI: 10.1186/s12885-020-06818-0.

The anti-cancer effect of retinoic acid signaling in CRC occurs via decreased growth of ALDH+ colon cancer stem cells and increased differentiation of stem cells.

Modarai S, Gupta A, Opdenaker L, Kowash R, Masters G, Viswanathan V Oncotarget. 2018; 9(78):34658-34669.

PMID: 30410666 PMC: 6205182. DOI: 10.18632/oncotarget.26157.

References

Elizondo G, Medina-Diaz I . Induction of CYP3A4 by 1alpha,25-dyhydroxyvitamin D3 in HepG2 cells. Life Sci. 2003; 73(2):141-9. DOI: 10.1016/s0024-3205(03)00262-5. View

Molotkov A, Duester G . Genetic evidence that retinaldehyde dehydrogenase Raldh1 (Aldh1a1) functions downstream of alcohol dehydrogenase Adh1 in metabolism of retinol to retinoic acid. J Biol Chem. 2003; 278(38):36085-90. DOI: 10.1074/jbc.M303709200. View

Andreola F, Hayhurst G, Luo G, Ferguson S, Gonzalez F, Goldstein J . Mouse liver CYP2C39 is a novel retinoic acid 4-hydroxylase. Its down-regulation offers a molecular basis for liver retinoid accumulation and fibrosis in aryl hydrocarbon receptor-null mice. J Biol Chem. 2003; 279(5):3434-8. DOI: 10.1074/jbc.M305832200. View

Oyadomari S, Mori M . Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 2003; 11(4):381-9. DOI: 10.1038/sj.cdd.4401373. View

Han A, Marandici A, Monder C . Metabolism of corticosterone in the mouse. Identification of 11 beta, 20 alpha-dihydroxy-3-oxo-4-pregnen-21-oic acid as a major metabolite. J Biol Chem. 1983; 258(22):13703-7. View

MacKerell Jr A, Blatter E, Pietruszko R . Human aldehyde dehydrogenase: kinetic identification of the isozyme for which biogenic aldehydes and acetaldehyde compete. Alcohol Clin Exp Res. 1986; 10(3):266-70. DOI: 10.1111/j.1530-0277.1986.tb05087.x. View

Giguere V, Ong E, Segui P, Evans R . Identification of a receptor for the morphogen retinoic acid. Nature. 1987; 330(6149):624-9. DOI: 10.1038/330624a0. View

Haselbeck R, Hoffmann I, Duester G . Distinct functions for Aldh1 and Raldh2 in the control of ligand production for embryonic retinoid signaling pathways. Dev Genet. 1999; 25(4):353-64. PMC: 4342002. DOI: 10.1002/(SICI)1520-6408(1999)25:4<353::AID-DVG9>3.0.CO;2-G. View

Pinazo-Duran M, Verdejo C, Azorin I, Renau-Piqueras J, Iborra F . Colocalization of aldehyde dehydrogenases and Fe/NADPH-induced lipid peroxidation in tissue sections of rat retina. Ophthalmic Res. 2000; 32(2-3):61-8. DOI: 10.1159/000055591. View

10.

Elizondo G, Corchero J, Sterneck E, Gonzalez F . Feedback inhibition of the retinaldehyde dehydrogenase gene ALDH1 by retinoic acid through retinoic acid receptor alpha and CCAAT/enhancer-binding protein beta. J Biol Chem. 2000; 275(50):39747-53. DOI: 10.1074/jbc.M004987200. View

11.

Vasiliou V, Pappa A, Petersen D . Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. Chem Biol Interact. 2001; 129(1-2):1-19. DOI: 10.1016/s0009-2797(00)00211-8. View

12.

Shimada J, Suzuki Y, Kim S, Wang P, Matsumura M, Kojima S . Transactivation via RAR/RXR-Sp1 interaction: characterization of binding between Sp1 and GC box motif. Mol Endocrinol. 2001; 15(10):1677-92. DOI: 10.1210/mend.15.10.0707. View

13.

Kim S, Kim H, Jung D, Lee S, Kim Y, Kim J . Retinoid-dependent antagonism of serum response factor transactivation mediated by transcriptional coactivator proteins. Oncogene. 2001; 20(45):6638-42. DOI: 10.1038/sj.onc.1204695. View

14.

Deindl E, Boengler K, van Royen N, Schaper W . Differential expression of GAPDH and beta3-actin in growing collateral arteries. Mol Cell Biochem. 2002; 236(1-2):139-46. DOI: 10.1023/a:1016166127465. View

15.

Guimond J, Devost D, Brodeur H, Mader S, Bhat P . Characterization of the rat RALDH1 promoter. A functional CCAAT and octamer motif are critical for basal promoter activity. Biochim Biophys Acta. 2002; 1579(2-3):81-91. DOI: 10.1016/s0167-4781(02)00510-9. View

16.

Nagpal S, Cai J, Zheng T, Patel S, Masood R, Lin G . Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma. Mol Cell Biol. 1997; 17(7):4159-68. PMC: 232269. DOI: 10.1128/MCB.17.7.4159. View

17.

Andreola F, Fernandez-Salguero P, Chiantore M, Petkovich M, Gonzalez F, De Luca L . Aryl hydrocarbon receptor knockout mice (AHR-/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res. 1997; 57(14):2835-8. View

18.

DiSepio D, Malhotra M, Chandraratna R, Nagpal S . Retinoic acid receptor-nuclear factor-interleukin 6 antagonism. A novel mechanism of retinoid-dependent inhibition of a keratinocyte hyperproliferative differentiation marker. J Biol Chem. 1997; 272(41):25555-9. DOI: 10.1074/jbc.272.41.25555. View

19.

Sabatakos G, Davies G, Grosse M, Cryer A, Ramji D . Expression of the genes encoding CCAAT-enhancer binding protein isoforms in the mouse mammary gland during lactation and involution. Biochem J. 1998; 334 ( Pt 1):205-10. PMC: 1219680. DOI: 10.1042/bj3340205. View

20.

Gonzalez F . The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab Dispos. 1998; 26(12):1194-8. View